Omalizumab May Improve Tolerance to Venom Immunotherapy | HCPLive A new study found that adjunct omalizumab helped most patients safely continue honeybee venom immunotherapy after prior severe allergic reactions.

New study suggests #omalizumab may help patients safely continue honeybee venom immunotherapy after severe allergic reactions.
Read more: www.hcplive.com/view...
#Allergy #Immunology # #VenomImmunotherapy